Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eculizumab to Enable Renal Transplantation in Patients With History of Antiphospholipid Antibody Syndrome or Catastrophic Antiphospholipid Antibody Syndrome

NCT01029587 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT01029587
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01029587 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eculizumab to Enable Renal Transplantation in Patients With History of Antiphospholipid Antibody Syndrome or Catastrophic Antiphospholipid Antibody Syndrome
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
May 6, 2010
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid antibody syndrome, end stage renal disease